The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
Jens Hillengass, MD, shares a history of myeloma imaging, the variety of sophisticated imaging techniques available, and shares several examples to help determine diagnosis.
Phillip McCarthy, MD, discusses autologous stem cell transplant/rescue following induction therapy, available therapies, and why a majority of patients will have progressive disease.
Hillary Jacobson, DPT, shares the importance of exercise in reducing fatigue in patients diagnosed with cancer.
Ryan Hare, PharmD, discusses the treatment of Myeloma Bone Disease. This lecture will review the myeloma bone microenvironment, discuss bone preservation benefits of treatments, describe aniti-myeloma properties, and highlight medication ...
Kelvin Lee, MD, gives a “philosophical talk” regarding novel treatment approaches in myeloma. This lecture helps illustrate the way doctors think about drugs and treatments for treating myeloma.
Patients who develop cytomegalovirus (CMV) infections after allogeneic stem cell transplantation may be able to develop an immunity against the virus, strengthen their immune system and reduce reliance on strong antiviral medications, ...
Roswell Park researchers are working on strategies to modulate the immune response to cancer treatment and control by overcoming immunosuppression.
The goal of this activity is to review currently available CAR T-Cell therapies for diffuse large B-cell lymphoma. Topics to be covered include patient eligibility criteria, complications, outcomes and treatment guidelines.
This site is intended for healthcare professionals